Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan vs Candesartan in Heart Failure
NCT00679484Phase 3Terminated
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of olmesartan in chronic heart failure (CHF), sponsored by Daiichi Sankyo Co., Ltd.. Started Jun 2008; status: terminated.
02
Drugs
olmesartan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT00679484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679484.